Gyre Therapeutics Inc (NASDAQ:GYRE) price closed higher on Friday, June 27, and jumping 0.54% above its previous close.
A look at the daily price movement shows that the last close reads $7.38, with intraday deals fluctuated between $7.2 and $7.5973. The company’s P/E ratio in the trailing 12-month period read 154.91. Taking into account the 52-week price action we note that the stock hit a 52-week high of $19.00 and 52-week low of $6.11. The stock subtracted -21.40% on its value in the past month.
Gyre Therapeutics Inc, which has a market valuation of $670.20 million, is expected to release its quarterly earnings report on 2025-May-09.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give GYRE a short term outlook of 100% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Sell, while an average of long term indicators are currently assigning the stock as 100% Sell.
The overview shows that GYRE’s price is at present -8.42% off the SMA20 and -18.06% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 39.41, with weekly volatility standing at 6.59%. The indicator jumps to 7.58% when calculated based on the past 30 days. Gyre Therapeutics Inc (NASDAQ:GYRE)’s beta value is holding at 1.69.
An analysis of the Gyre Therapeutics Inc (NASDAQ:GYRE) stock in terms of its daily trading volume indicates that the 3-month average is 234.04K. However, this figure increases on the past 10-day timeline to an average of 0.25 million.
Current records show that the company has 87.64M in outstanding shares. The insiders’ percentage holdings are 81.99% of outstanding shares while the percentage share held by institutions stands at 2.89%. The stats also highlight that short interest as of 2025-06-13, stood at 1.41 million shares, which puts the short ratio at the time at 3.85. From this we can glean that short interest is 958.00 of company’s current outstanding shares. Notably, we see that shares short in June fall slightly given the previous month’s figure stood at 2.48 million. But the -25.20% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
